Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is -35.28% vs -23.50% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is -38.89% vs -20.39% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
Compare Quarterly Results Of Cogent Biosciences, Inc. With
Quarterly - Net Sales
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 4.98% vs -26.70% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -35.28% vs -23.50% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is -4.27% vs -19.59% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -38.89% vs -20.39% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is -7.69% vs -13.33% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Mar 2025






